Skip to content

Non-invasive Negative Pressure Treatment for Pectus Excavatum

Efficacy Evaluation of the Non-invasive Negative Pressure Treatment for Pectus Excavatum

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01816373
Enrollment
30
Registered
2013-03-22
Start date
2013-03-31
Completion date
2016-10-31
Last updated
2017-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pectus Excavatum

Keywords

Chest wall; Chest, funnel; pectus excavatum; congenital abnormality

Brief summary

The purpose of this study is to determine whether the non-invasive negative pressure treatment with the use of the device Vacuum Bellfor is effective for the pectus excavatum treatment

Interventions

Patients with pectus excavatum will be submitted to a negative pressure treatment with the Vacuum Bell device

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* absence of co-morbidities that may interfere with proper placement or function of the apparatus * test negative for pregnancy in women of childbearing age

Exclusion criteria

* skeletal diseases like osteogenesis imperfecta or osteoporosis * clotting disorders such as hemophilia or thrombopathia * skin diseases or infections of the anterior chest wall * angiopathies or vascular fragility * obesity important with BMI greater than 30 * precarious commitment to the prolonged use of the device protocol

Design outcomes

Primary

MeasureTime frameDescription
Measurement of the reduction in the deepness of the pectus excavatum3 monthsThe patients will be submitted to clinical measurement of their anterior chest wall at three months interval until the closing of the study

Secondary

MeasureTime frameDescription
Evaluation of quality of life related to self-esteemOne yearThe patients and their parents will be submitted to a quality of life questionnaire in the beginning and after one year using the device

Other

MeasureTime frameDescription
Evaluate the safety and adherence to the treatmentthree monthsThe patients will be followed to assure adherence and safety of the treatment

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026